The neural pathway of galanin in the hypothalamic arcuate nucleus of rats: Activation of beta-endorphinergic neurons projecting to periaqueductal gray matter

Journal of Neuroscience Research

Volumn 85, Issue 11, 2007, Pages 2400-2406

  Sun, Yan Gang ^a,b   Gu, Xing Long ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Arcuate nucleus; Beta endorphin; Midbrain periaqueductal gray matter (PAG); Mu opioid receptor

Indexed keywords

BETA ENDORPHIN; BETA FUNALTREXAMINE; GALANIN; NALOXONE;

ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HYPOTHALAMUS; IMMUNOFLUORESCENCE; MESENCEPHALON; NERVE TRACT; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT;

ANIMALS; ARCUATE NUCLEUS; BETA-ENDORPHIN; FLUORESCENT ANTIBODY TECHNIQUE; GALANIN; HEAT; HINDLIMB; INJECTIONS, INTRAVENTRICULAR; MALE; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NEURAL PATHWAYS; NEURONS; PAIN; PERIAQUEDUCTAL GRAY; PHYSICAL STIMULATION; RATS; RATS, WISTAR;

EID: 34547620676     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21396     Document Type: Article

References (48)

1. Behbehani MM. 1995. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46:575-605.
2. Bernal SA, Morgan MM, Craft RM. 2007. PAG mu opioid receptor activation underlies sex differences in morphine antinociception. Behav Brain Res 177:126-133.
3. Blakeman KH, Holmberg K, Hao JX, Xu XJ, Kahl U, Lendahl U, Bartfai T, Wiesenfeld-Hallin Z, Hokfelt T. 2001. Mice over-expressing galanin have elevated heat nociceptive threshold. Neuroreport 12:423-425.
4. Bonnefond C, Palacios JM, Probst A, Mengod G. 1990. Distribution of galanin mRNA containing cells and galanin receptor binding sites in human and rat hypothalamus. Eur J Neurosci 2:629-637.
5. Bouret S, Prevot V, Croix D, Howard A, Habert-Ortoli E, Jegou S, Vaudry H, Beauvillain JC, Mitchell V. 2000. Expression of GalR1 and GalR2 galanin receptor messenger ribonucleic acid in proopiomelanocortin neurons of the rat arcuate nucleus: effect of testosterone. Endocrinology 141:1780-1794.
6. Bouret S, Croix D, Mariot M, Loyens A, Prevot V, Jegou S, Vaudry H, Beauvillain JC, Mitchell V. 2002. Galanin modulates the activity of proopiomelanocortin neurons in the isolated mediobasal hypothalamus of the male rat. Neuroscience 112:475-485.
7. Brewer A, Echevarria DJ, Langel U, Robinson JK. 2005. Assessment of new functional roles for galanin in the CNS. Neuropeptides 39:323-326.
8. Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR. 2000. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine. J Pharmacol Exp Ther 294:933-940.
9. Finley JC, Lindstrom P, Petrusz P. 1981. Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33:28-42.
10. Flatters SJ, Fox AJ, Dickenson AH. 2002. Nerve injury induces plasticity that results in spinal inhibitory effects of galanin. Pain 98:249-258.
11. Flatters SJ, Fox AJ, Dickenson AH. 2003. In vivo and in vitro effects of peripheral galanin on nociceptive transmission in naive and neuropathic states. Neuroscience 116:1005-1012.
12. Ge Y, Lundeberg T, Yu LC. 2002. Blockade effect of mu and kappa opioid antagonists on the anti-nociception induced by intra-periaqueductal grey injection of oxytocin in rats. Brain Res 927:204-207.
13. Gu XL, Yu LC. 2007. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats. J Pain 8:85-90.
14. Horvath TL, Kalra SP, Naftolin F, Leranth C. 1995. Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol 7:579-588.
15. Liu H, Hokfelt T. 2000. Effect of intrathecal galanin and its putative antagonist M35 on pain behavior in a neuropathic pain model. Brain Res 886:67-72.
16. Liu HX, Hokfelt T. 2002. The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci 23:468-474.
17. Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, Hodzic L, Pou C, Godbout C, Hokfelt T. 2001. Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci U S A 98:9960-9964.
18. 3H]beta-funaltrexamine. Mol Pharmacol 32:321-329.
19. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ. 1987. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464.
20. Mansour A, Fox CA, Akil H, Watson SJ. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29.
21. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. Sydney: Academic Press.
22. Pilcher WH, Joseph SA, McDonald JV. 1988. Immunocytochemical localization of pro-opiomelanocortin neurons in human brain areas subserving stimulation analgesia. J Neurosurg 68:621-629.
23. Pogozheva ID, Przydzial MJ, Mosberg HI. 2005. Homology modeling of opioid receptor-ligand complexes using experimental constraints. AAPS J 7:E434-E448.
24. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, Kahl U, Hao JX, Xu XJ, Wiesenfeld-Hallin Z, Hokfelt T, Bartfai T, Langel U. 1998. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 16:857-861.
25. Przewlocki R, Przewlocka B. 2001. Opioids in chronic pain. Eur J Pharmacol 429:79-91.
26. Sandkuhler J. 1996. The organization and function of endogenous antinociceptive systems. Prog Neurobiol 50:49-81.
27. Satoh M, Minami M. 1995. Molecular pharmacology of the opioid receptors. Pharmacol Ther 68:343-364.
28. Satoh M, Kubota A, Iwama T, Wada T, Yasui M, Fujibayashi K, Takagi H. 1983. Comparison of analgesic potencies of mu, delta and kappa agonists locally applied to various CNS regions relevant to analgesia in rats. Life Sci 33(Suppl 1):689-692.
29. Sim LJ, Joseph SA. 1991. Arcuate nucleus projections to brainstem regions which modulate nociception. J Chem Neuroanat 4:97-109.
30. Sun YG, Gu XL, Lundeberg T, Yu LC. 2003a. An antinociceptive role of galanin in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation. Pain 106:143-150.
31. Sun YG, Lundeberg T, Yu LC. 2003b. Involvement of endogenous beta-endorphin in antinociception in the arcuate nucleus of hypothalamus in rats with inflammation. Pain 104:55-63.
32. Takemori AE, Portoghese PS. 1985. Affinity labels for opioid receptors. Annu Rev Pharmacol Toxicol 25:193-223.
33. Takemori AE, Larson DL, Portoghese PS. 1981. The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone. Eur J Pharmacol 70:445-451.
34. Vanegas H, Schaible HG. 2004. Descending control of persistent pain: inhibitory or facilitatory? Brain Res Brain Res Rev 46:295-309.
35. Walton KM, Chin JE, Duplantier AJ, Mather RJ. 2006. Galanin function in the central nervous system. Curr Opin Drug Discov Dev 9:560-570.
36. Wang D, Ye HH, Yu LC, Lundeberg T. 1999. Intra-periaqueductal grey injection of galanin increases the nociceptive response latency in rats, an effect reversed by naloxone. Brain Res 834:152-154.
37. Wang D, Lundeberg T, Yu LC. 2000. Antinociceptive role of galanin in periaqueductal grey of rats with experimentally induced mononeuropathy. Neuroscience 96:767-771.
38. Ward SJ, Portoghese PS, Takemori AE. 1982. Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine. J Pharmacol Exp Ther 220:494-498.
39. Wiesenfeld-Hallin Z, Xu XJ, Crawley JN, Hokfelt T. 2005. Galanin and spinal nociceptive mechanisms: Recent results from transgenic and knock-out models. Neuropeptides 39:207-210.
40. Xiong W, Yu LC. 2006. Involvement of endogenous cholecystokinin in tolerance to morphine antinociception in the nucleus accumbens of rats. Behav Brain Res 173:116-121.
41. Xiong W, Gao L, Sapra A, Yu LC. 2005. Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid systems. Regul Pept 132:85-90.
42. Xu SL, Zhang YP, Lundeberg T, Yu LC. 2000. Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation. Regul Pept 95:19-23.
43. Yu LC, Lundeberg S, An H, Wang FX, Lundeberg T. 1999. Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy. Life Sci 64:1145-1153.
44. Yu LC, Xu SL, Xiong W, Lundeberg T. 2001. The effect of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats. Regul Pept 101:179-182.
45. Zhang X, Xu ZO, Shi TJ, Landry M, Holmberg K, Ju G, Tong YG, Bao L, Cheng XP, Wiesenfeld-Hallin Z, Lozano A, Dostrovsky J, Hokfelt T. 1998. Regulation of expression of galanin and galanin receptors in dorsal root ganglia and spinal cord after axotomy and inflammation. Ann N Y Acad Sci. 863:402-413.
46. Zimmerman DM, Leander JD, Reel JK, Hynes MD. 1987. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands. J Pharmacol Exp Ther 241:374-378.
47. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.
48. Zsarnovszky A, Horvath TL, Naftolin F, Leranth C. 2000. AMPA receptors colocalize with neuropeptide-Y- and galanin-containing, but not with dopamine, neurons of the female rat arcuate nucleus: a semiquantitative immunohistochemical colocalization study. Exp Brain Res 133:532-537.